X4 Pharmaceuticals (XFOR) Receivables - Net (2020 - 2025)
X4 Pharmaceuticals (XFOR) reported Receivables - Net of $573000.0 for Q4 2025, down 46.45% on a YoY basis from $1.1 million in Q4 2024, and down 35.69% quarter-over-quarter from $891000.0 in Q3 2025.
X4 Pharmaceuticals (XFOR) Receivables - Net (2020 - 2025) Analysis & Trends
X4 Pharmaceuticals has reported Receivables - Net for 3 years, with the latest figure at $573000.0 in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net fell 46.45% year-over-year to $573000.0; the trailing twelve-month figure through Dec 2025 stood at $573000.0 (down 46.45% YoY), and the FY2025 full-year result was $573000.0, down 46.45% from the prior year.
- Receivables - Net for Q4 2025 stood at $573000.0, down from $891000.0 in the prior quarter.
- The five-year high for Receivables - Net was $1.1 million in Q2 2025, with the low at $509000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | X4 Pharmaceuticals | 156.06 Mn | 156.06 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 573,000.00 |
| Dec 31, 2025 | 573,000.00 |
| Sep 30, 2025 | 891,000.00 |
| Sep 30, 2025 | 891,000.00 |
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 509,000.00 |
| Mar 31, 2025 | 509,000.00 |
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 3.00 Mn |
| Mar 31, 2020 | 3.00 Mn |
| Mar 31, 2020 | 3.00 Mn |